20, it became the first drug approved by the U.S. Food and Drug Administration (FDA) to treat obstructive sleep apnea. In the trial that Lilly, the drug's manufacturer, submitted in April to the ...

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...